StonvexLoading…
StonvexStonvexStonvexCore line items from DRVN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2024 2024-12-28 | Annual 2023 2023-12-30 | Annual 2022 2022-12-31 | Annual 2021 2021-12-25 |
|---|---|---|---|---|
Revenue | $2.34B | $2.30B | $2.03B | $1.47B |
Operating Income | $-140.23M | $-686.53M | $199.60M | $177.06M |
Net Income | $-292.50M | $-744.96M | $43.19M | $9.63M |
EPS (Diluted) | $-1.82 | $-4.53 | $0.25 | $0.06 |
Total Assets | $5.26B | $5.91B | $6.50B | $5.86B |
Total Liabilities | $4.65B | $5.00B | $4.85B | $4.21B |
Cash & Equivalents | $169.95M | $176.52M | $227.11M | $523.41M |
Free Cash Flow OCF − CapEx | $-47.06M | $-361.31M | $-239.03M | $123.07M |
Shares Outstanding | 163.84M | 163.97M | 167.40M | 167.38M |